[PS 01-18] MECHANISM OF HYPERTENSIVE CARDIAC HYPERTROPHY IN CULTURED NEONATAL RAT VENTRICULAR CARDIAC MYOCYTES. (September 2016)
- Record Type:
- Journal Article
- Title:
- [PS 01-18] MECHANISM OF HYPERTENSIVE CARDIAC HYPERTROPHY IN CULTURED NEONATAL RAT VENTRICULAR CARDIAC MYOCYTES. (September 2016)
- Main Title:
- [PS 01-18] MECHANISM OF HYPERTENSIVE CARDIAC HYPERTROPHY IN CULTURED NEONATAL RAT VENTRICULAR CARDIAC MYOCYTES
- Authors:
- Sun, Gang
Yu, Hui
Wang, Zhanli
Yang, Xiaomin
Yue, Jianwei
Qu, Shuangli - Abstract:
- Abstract : Objective: hypertrophy and impaired cardiac function are commonly observed in some patients with hypertension. Angiotensin II is a critical growth factor to mediate cardiac hypertrophy. MicroRNAs (miRs) have been identified and associated with several cardiovascular diseases, including ischemic cardiomyopathy and cardiac hypertrophy. MiR-21 was reported to be upregulated during adult rat cardiac remodeling. The importance of miR-21* in cardiomyocyte hypertrophy has also been demonstrated. Design and Method: Wistar rats (weight, 120–150 g) were purchased. Ventricular cardiomyocytes were isolated from 1 to 2-day-old neonatal wistar rat as described previously with minor modification. After 24 h of serum starvation, the cardiomyocytes were stimulated with or without 1 umol/L Ang II for 48 h. The hypertrophy cardiomyocytes were identified by semi-quantitative RT-PCR assay. Total miRNAs were extracted using mirVANA miRNA isolation kit. The miRNAs quality and quantity were determined by a NanoDrop 1000 Spectrophotometer. The miRNAs were reverse transcribed by TaqMan MicroRNA Reverse Transcription Kit. qRT-PCR was performed using TaqMan Universal PCR Master Mix II on the ABI 7500 System according to the manufacturer's recommendations. Total proteins isolated from cultured cardiomyocytes, with or without 1 umlo/L Ang II for 48 h, were prepared by M-PER mammalian protein extraction reagent. SDS-polyacrylamide gel electrophoresis was performed using standard procedures.Abstract : Objective: hypertrophy and impaired cardiac function are commonly observed in some patients with hypertension. Angiotensin II is a critical growth factor to mediate cardiac hypertrophy. MicroRNAs (miRs) have been identified and associated with several cardiovascular diseases, including ischemic cardiomyopathy and cardiac hypertrophy. MiR-21 was reported to be upregulated during adult rat cardiac remodeling. The importance of miR-21* in cardiomyocyte hypertrophy has also been demonstrated. Design and Method: Wistar rats (weight, 120–150 g) were purchased. Ventricular cardiomyocytes were isolated from 1 to 2-day-old neonatal wistar rat as described previously with minor modification. After 24 h of serum starvation, the cardiomyocytes were stimulated with or without 1 umol/L Ang II for 48 h. The hypertrophy cardiomyocytes were identified by semi-quantitative RT-PCR assay. Total miRNAs were extracted using mirVANA miRNA isolation kit. The miRNAs quality and quantity were determined by a NanoDrop 1000 Spectrophotometer. The miRNAs were reverse transcribed by TaqMan MicroRNA Reverse Transcription Kit. qRT-PCR was performed using TaqMan Universal PCR Master Mix II on the ABI 7500 System according to the manufacturer's recommendations. Total proteins isolated from cultured cardiomyocytes, with or without 1 umlo/L Ang II for 48 h, were prepared by M-PER mammalian protein extraction reagent. SDS-polyacrylamide gel electrophoresis was performed using standard procedures. Results: We demonstrated that miR-21* was markedly upregualted in Ang II-induced neonatal rat cardiac myocytes, while miR-21 was reduced. We might speculate that the miRNA expression profile is different between neonatal rat and adult rat cardiac myocytes. Our results further showed that Ang II led to a significant reduction of PTEN expression level and a significant promotion of phosphorylation level of PI3K. In contrast, treatment with prohypertrophic molecule Ang II reduced the phosphorylation level of Akt. Conclusions: We therefore speculate that miR-21* might have two opposite effects on Ang II-induced cardiac hypertrophy through various signaling pathways. … (more)
- Is Part Of:
- Journal of hypertension. Volume 34:(2016) Supplement 1
- Journal:
- Journal of hypertension
- Issue:
- Volume 34:(2016) Supplement 1
- Issue Display:
- Volume 34, Issue 1 (2016)
- Year:
- 2016
- Volume:
- 34
- Issue:
- 1
- Issue Sort Value:
- 2016-0034-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2016-09
- Subjects:
- Hypertension -- Periodicals
Hypertension -- Periodicals
616.132005 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://journals.lww.com/jhypertension/pages/default.aspx ↗
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00004872-000000000-00000 ↗
http://www.jhypertension.com/ ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1097/01.hjh.0000500119.65678.e4 ↗
- Languages:
- English
- ISSNs:
- 1473-5598
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5004.510000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 2418.xml